
Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …
Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

